This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iglarz, M. Articles by Lévy, B. I. Search for Related Content PubMed PubMed Citation Articles by Iglarz, M. Articles by Lévy, B. I. Related Collections Cardiovascular Pharmacology Angiogenesis Other Vascular biology

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1598.)
© 2001 American Heart Association, Inc.

Vascular Biology

Chronic Blockade of Endothelin Receptors Improves Ischemia-Induced Angiogenesis in Rat Hindlimbs Through Activation of Vascular Endothelial Growth Factor–NO Pathway

Marc Iglarz; Jean-Sébastien Silvestre; Micheline Duriez; Daniel Henrion; Bernard I. Lévy

From the Institut National de la Santé et de la Recherche Médicale U541, IFR Circulation-Lariboisière, Université Paris VII, and the Department of Physiology (B.I.L.), AP-HP Hôpital Lariboisière, Paris, France.

Reprint requests to Daniel Henrion, PhD, INSERM U541, 41 Bd de la Chapelle, Hôpital Lariboisière, 75475 Paris cedex 10, France. E-mail daniel.henrion{at}inserm.lrb.ap-hop-paris.fr

Abstract—— This study investigated in vivo the putative angiogenic role of endothelin (ET)-1 in a model of ischemia-induced angiogenesis. Ischemia was produced by unilateral femoral artery occlusion in Wistar rats submitted to either chronic ET-1 infusion (2 nmol · kg^-1 · min^-1) or to a dual ET_A/ET_B receptor antagonist (bosentan, 100 mg · kg^-1 · d^-1) for 3 and 28 days. Arterial density was evaluated by microangiography and measurement of capillary and arteriolar density in hindlimb muscles. ET-1 infusion had no effect on ischemia-induced angiogenesis and was associated with a slight decrease in vascular endothelial growth factor (VEGF) content measured by Western blot analysis. Conversely, bosentan induced a marked increase in vessel density at 3 and 28 days (1.4-fold and 1.7-fold, respectively, compared with no treatment; P<0.05), which was associated with an increase in VEGF and endothelial NO synthase levels in ischemic legs (by 31±8% and 45±23%, respectively, at 3 days and by 65±13% and 55±15%, respectively, at 28 days; P<0.05 versus nontreated rats). At day 28, the proangiogenic effect of bosentan was abolished when NO synthesis inhibitor N^G-nitro-L-arginine methyl ester (10 mg · kg^-1 · d^-1) or VEGF-neutralizing antibody (2.5 µg/kg twice a week) were coadministered with bosentan. Those results provide the first evidence of an early and sustained proangiogenic effect of endothelin antagonism associated with an upregulation of VEGF and endothelial NO synthase in vivo.

Key Words: endothelin-1 • angiogenesis • vascular endothelial growth factor • nitric oxide • ischemia

This article has been cited by other articles:

				E. I. Ager, J. Neo, and C. Christophi The renin-angiotensin system and malignancy Carcinogenesis, September 1, 2008; 29(9): 1675 - 1684. [Abstract] [Full Text] [PDF]

				S. Jesmin, S. Zaedi, N. Shimojo, M. Iemitsu, K. Masuzawa, N. Yamaguchi, C. N. Mowa, S. Maeda, Y. Hattori, and T. Miyauchi Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1030 - E1040. [Abstract] [Full Text] [PDF]

				Z. W. Zhuang, L. Gao, M. Murakami, J. D. Pearlman, T. J. Sackett, M. Simons, and E. D. de Muinck Arteriogenesis: Noninvasive Quantification with Multi-Detector Row CT Angiography and Three-dimensional Volume Rendering in Rodents Radiology, September 1, 2006; 240(3): 698 - 707. [Abstract] [Full Text] [PDF]

				T. Carpenter, S. Schomberg, W. Steudel, J. Ozimek, K. Colvin, K. Stenmark, and D. D. Ivy Endothelin B Receptor Deficiency Predisposes to Pulmonary Edema Formation via Increased Lung Vascular Endothelial Cell Growth Factor Expression Circ. Res., September 5, 2003; 93(5): 456 - 463. [Abstract] [Full Text] [PDF]